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Here we tested the hypothesis whether IP 3 itself is involved in the activation of NFAT in atrial and ventricular myocytes from rabbits. We analyzed the subcellular localization of NFATc1-green fluorescent protein (GFP) and NFATc3-GFP fusion proteins in response to neurohumoral agonists and direct administration of IP 3 and quantified it as the ratio of nuclear NFAT to cytoplasmic NFAT (NFAT Nuc /NFAT Cyt ). We present direct evidence that IP 3 induced nuclear accumulation of NFATc1 followed by increased NFAT-dependent transcriptional activity in atrial myocytes but not in ventricular cells. In contrast, the same agonists failed to significantly activate NFATc3 in rabbit atrial and ventricular myocytes. Taken together, we demonstrate that IP 3 -dependent Ca 2ϩ release directly activates NFATc1 in adult atrial myocytes.
MATERIALS AND METHODS

Isolation, cell culture, and viral transduction of cardiac myocytes.
Atrial and ventricular myocytes from New Zealand white rabbits were isolated as previously described (6) . The procedure was approved by the Institutional Animal Care and Use Committee. Briefly, animals of either sex were anesthetized and hearts were removed quickly and mounted on a Langendorff perfusion apparatus. The heart was then retrogradely perfused via the aorta, and single myocytes were obtained after perfusion with a Liberase Blendzyme 4 (Roche Applied Science, Indianapolis, IN) containing solution. Ca 2ϩ -tolerant myocytes were obtained by slow adaptation to the final Ca 2ϩ concentration of the culture medium, and the cells were cultured on sterile, laminin-coated glass coverlips in medium 199, supplemented with 25 g/ml gentamycin and 25 g/ml kanamycin (all Mediatech, Hernon, VA). The cells were infected with adenoviruses (Ad) for NFATc1-GFP or NFATc3-GFP (28) and were imaged 48 h after infection. NFAT-GFP fusion proteins are widely used to study NFAT in living cells because they behave similarly to endogenous proteins (4, 9, 14, 18, 26, 28, 29) .
Solutions and chemicals. During the experiments, the cells were bathed in a HBSS containing (in mM) 135 NaCl, 4 KCl, 1 MgCl 2, 2 CaCl2, 10 glucose, and 10 HEPES (pH ϭ 7.3 with NaOH). Agonists or antagonists were prepared in HBSS for acute experiments or added to the cell culture medium for overnight incubations. All chemicals, agonists, or inhibitors were purchased from Sigma (St. Louis, MO) or Tocris (Ellisville, MO). The cell-permeable IP 3 acetoxymethyl ester (IP3-AM) was from SiChem (Bremen, Germany).
Fluorescence measurements of NFAT-GFP. The subcellular localization of NFAT-GFP was analyzed with confocal microscopy (BioRad Radiance 2000/MP). GFP was excited with an argon ion laser line at 488 nm, and emitted fluorescence was collected at 500 -520 nm. The subcellular distribution of NFAT-GFP was quantified as NFAT Nuc/ NFATCyt (26, 28) using a region of interest (ROI) that covered the area of the nucleus (NFATNuc) and a cytoplasmic ROI (NFATCyt) of the same size (number of pixels). Images were background sub- tracted, and the mean fluorescence of a particular ROI was analyzed using ImageJ (Wayne Rasband, National Institutes of Health, Bethesda, MD).
Staining of cell nuclei with SYTO-59. To identify nuclei, cardiomyocytes were stained for 30 min with 5 M of the membranepermeable DNA dye SYTO-59 (Invitrogen/Molecular Probes, Carlsbad, CA). For confocal imaging, the cells were excited at 637 nm (red diode laser) and emitted fluorescence was collected at Ͼ 660 nm. The colocalization of SYTO-59 and NFAT-GFP was used to confirm the nuclear localization of NFAT (26) .
In vivo assay for transcriptional activity of NFAT. To monitor the transcriptional activity of NFAT in living cells, atrial myocytes were double infected with Ad-NFAT-red fluorescent protein (RFP) (27) , which expresses RFP under control of a NFAT-sensitive interleukin-2 promoter, and with Ad-NFATc1-GFP. After infections (24 h), a subset of cells was stimulated with 100 nM ET-1 overnight and red fluorescence was measured on the next day. RFP was excited at 535 nm (green He-Ne laser line), and emitted fluorescence was collected at Ͼ 570 nm. NFAT-GFP was imaged as described in Fluorescence measurements of NFAT-GFP. To avoid the detection of GFP emission in the RFP channel, GFP and RFP images were taken sequentially, avoiding simultaneous excitation. The mean fluorescence of RFP was averaged over the entire surface area of the cell.
Data analysis and presentation. Data are presented as individual observations or as means Ϯ SE and were analyzed using Student's t-test; n represents the number of individual cells, and differences were considered significant at P Ͻ 0.05.
RESULTS
Basal localization of NFATc1 and NFATc3 in resting
myocytes. Subcellular localizations of NFATc1-and NFATc3-GFP fusion proteins were analyzed with confocal microscopy 48 h after infections. The isoform NFATc1 was localized to the nucleus in resting atrial (Fig. 1A,a) and ventricular (Fig. 1B,a) myocytes. The corresponding nuclei were stained with SYTO-59 in atrial (Fig. 1A,b) and ventricular (Fig. 1B,b) myocytes. The average NFAT Nuc /NFAT Cyt ratios were 9.82 Ϯ 0.36 (n ϭ 234) for atrial myocytes and 9.08 Ϯ 0.33 (n ϭ 126) for ventricular myocytes. The line profiles of the raw fluorescence intensities of NFATc1-GFP and SYTO-59 across the nucleus overlap, confirming localization to the same cellular compartment in atrial (Fig. 1A,c) and ventricular (Fig. 1B,c) myocytes. In contrast, the isoform NFATc3-GFP was distributed to the cytoplasm of atrial (Fig. 1A,d ) and ventricular (Fig.  1B,d) myocytes, indicated by different staining of the corresponding nuclei (atria, Fig. 1A,e; and ventricle, Fig. 1B,e) and not overlapping fluorescence intensity profiles (atrial, Fig. 1A,f; and ventricle, Fig. 1B,f) . The average NFAT Nuc /NFAT Cyt ratios were 0.34 Ϯ 0.03 (n ϭ 66) for atrial myocytes and 0.59 Ϯ 0.05 (n ϭ 23) for ventricular myocytes. The basal nuclear localization of NFATc1 is consistent with our recent data from adult cat myocytes (28) . The cytoplasmic distribution of NFATc3 is due to the enhanced regulation of this isoform by nuclear export processes (26, 29) .
We then investigated how the stimulation of the G q protein/ IP 3 pathway influences the nuclear accumulation of NFAT in adult myocytes.
G q protein-coupled agonists induced nuclear accumulation and transcriptional activity of NFATc1. Neurohumoral agonists (e.g., ET-1) have been linked to the activation of the CaN/NFAT pathway and to inducing hypertrophy (13, 35) . To test whether NFATc1 is regulated by the phospholipase C/IP 3 pathway, we stimulated atrial myocytes expressing NFATc1-GFP with the agonists ET-1 (100 nM, Fig. 2A ), ANG II (2 M, Fig. 2C ), or Phe (10 M, Fig. 2D ) overnight and analyzed the nuclear localization of NFATc1 with confocal microscopy. All agonists induced the enhanced nuclear accumulation of NFATc1, indicated by increases of NFAT Nuc /NFAT Cyt ratios between 25 and 50%, depending on the agonist used (Fig. 2,  A-D) . This effect was prevented by 2 M 2-aminoethoxydiphenyl borate (2-APB), which inhibits cardiac SR IP 3 R Ca 2ϩ release channels at this concentration (7) . The activation of NFATc1 was also sensitive to the inhibition of CaN with 1 M inhibitor of NFAT-CaN association-6 or 1 M cyclosporine A (Fig. 2, A-D) .
We further tested the hypothesis whether ET-1 stimulation induced not only the nuclear accumulation of NFATc1 but also NFAT-regulated transcriptional activity (Fig. 2B) . We mea- sured transcriptional activity of NFATc1-GFP with NFAT-RFP, a tool that allows analyzing transcriptional activity of NFAT dynamically in individual living cells (27) . Atrial myocytes were coinfected with NFATc1-GFP and NFAT-RFP. Indeed, overnight stimulation with ET-1 induced a 1.5-fold increase in RFP fluorescence (Fig. 2B) . The expression of NFAT-RFP alone did not result in a comparable RFP fluorescence intensity (data not shown).
In ventricular myocytes, where SR IP 3 Rs are expressed at a lower density compared with atrial tissue, all agonists tested did not induce the nuclear accumulation of NFATc1 (Fig. 2E) . These data suggest that IP 3 is directly involved in the activation of NFATc1 only in atrial tissue.
To test this hypothesis, we incubated atrial cells with 10 M of a membrane-permeable IP 3 -AM for 2 h and analyzed the nuclear localization of NFATc1-GFP. Indeed, the direct administration of IP 3 resulted in an enhanced nuclear localization of NFATc1, which was sensitive to 2-APB (Fig. 3A) . Overnight incubations with IP 3 -AM induced a nuclear accumulation that was comparable to agonist stimulations (ϳ25% increase in NFAT Nuc /NFAT Cyt ratio; Fig. 3B, left) . We have previously demonstrated that nuclear localization of NFAT in cardiac myocytes is negatively regulated by cellular kinases and nuclear export processes (28) . To test whether this pathway also influences NFATc1, we incubated atrial cells with 1 M alsterpaullone (inhibitor of glycogen synthase kinase 3), which resulted in a 75% increase in the nuclear localization of NFATc1. This effect was further facilitated by ET-1 in a 2-APB-sensitive manner (Fig. 3B, middle) . This additive effect was in the range of nuclear accumulation observed under the conditions of a full inhibition of nuclear export with 40 nM leptomycin B (Fig. 3B, right) . These data suggest that the nuclear localization of NFATc1 is influenced by export pathways. IP 3 activates the nuclear import machinery for NFATc1 to overcome these export rates.
NFATc3-GFP was not activated by the G q /IP 3 pathway. In contrast to NFATc1, the isoform NFATc3 was not activated by the G q protein-coupled agonists ET-1, ANG II, and Phe or by IP 3 -AM, neither in atrial (Fig. 4A) nor in ventricular (Fig. 4B ) cells. However, the inhibition of nuclear export with 40 nM leptomycin B resulted in a strong nuclear localization of NFATc3 in both types of myocytes. This result indicates that NFATc3 is accessible for nuclear import in rabbit myocytes but also confirms the observation that nuclear localization of NFATc3 is prevented and highly controlled by export mechanisms (10, 26) .
DISCUSSION
Transcription factors of the NFAT family are activated in cardiac myocytes during cardiac development and pathological cellular remodeling (24, 36) . Although the CaN-dependent activation of NFAT and the underlying Ca 2ϩ signals are well characterized in several excitable and nonexcitable cells (2, 11, 29, 33) , it is not fully understood how a Ca 2ϩ signal can activate NFAT in adult cardiac myocytes in the surroundings of the large and normal beat-to-beat Ca 2ϩ fluctuations (1, 20 ). Here we demonstrate that IP 3 is directly involved in the activation of NFATc1 in atrial myocytes. Three independent agonists (ET-1, ANG II, and Phe) enhanced the accumulation of NFATc1 in the nucleus (Fig. 2) . Several lines of evidence support a direct involvement of IP 3 in this process. 2-APB, an inhibitor of the SR IP 3 -dependent Ca 2ϩ release channels (IP 3 Rs), prevented agonist-induced nuclear translocation of NFATc1. Furthermore, the direct application of IP 3 in form of a cell-permeable IP 3 -AM induced the activation of NFAT c1 in atrial myocytes (Fig. 3) . The same agonists did not activate NFATc1 in ventricular cells (Fig. 2E) , an effect that may be explained by a lower density of IP 3 Rs in the ventricular SR membrane (7) . In atrial cells, ET-1 not only induced a stronger nuclear localization of NFATc1-GFP but also enhanced the transcriptional activity of NFATc1. By measuring nuclear NFATc1-GFP and NFAT-sensitive expression of RFP simultaneously in living cells, we observed a 1.5-fold increase in RFP expression after overnight stimulation with ET-1 (Fig. 2B ).
The precise Ca 2ϩ signal by which IP 3 activates NFAT remains to be clarified. Our previous work together with studies by others implicate at least three distinct mechanisms by which IP 3 may influence intracellular Ca 2ϩ signaling in cardiac myocytes. First, we showed that IP 3 -mediated Ca 2ϩ release can act as a locally restricted Ca 2ϩ source, e.g., around the nucleus. The nuclear envelope contains a significant amount of IP 3 Rs. IP 3 -mediated Ca 2ϩ release from the nuclear envelope dominates over RyR-mediated Ca 2ϩ release and controls nuclear Ca 2ϩ concentration (15, 37) . This is consistent with the demonstration that ET-1 induces intracellular Ca 2ϩ elevations that affect nuclear Ca 2ϩ concentration and activate NFAT in neonatal cardiac myocytes (13) . Second, we demonstrated cytosolic IP 3 R-mediated Ca 2ϩ release in the form of locally restricted Ca 2ϩ puffs (38 (8, 12, 26) . A recent study elegantly demonstrated that this pathway is also implicated in maintaining hypertrophy in adult cardiac myocytes (34) ; channel members of the transient receptor potential channel family are upregulated, resulting in enhanced transcriptional activity of NFAT (16, 23) . However, the isoform NFATc1 has not been implicated in cardiac hypertrophy [where NFATc3 plays a dominant role; (28, 31) ], and evidence is lacking that store-operated Ca 2ϩ entry is involved in the regulation of NFATc1 in the heart.
Aside from the differences in the IP 3 /Ca 2ϩ dependence of the regulation of NFAT isoforms (c1 vs. c3) in different tissues (atrium vs. ventricle), a striking difference between isoforms c1 and c3 is their basal subcellular distribution. Whereas under basal resting conditions NFATc3 is predominantly localized to the cytosol, NFATc1 resides in the nucleus. Furthermore, as shown here, in atrial myocytes the extent of nuclear localization is modulated by IP 3 /Ca 2ϩ signaling. While NFATc3 has been undoubtedly linked to cardiac hypertrophy [e.g., NFATc3-deficient mice have a reduced ability to develop CaN-dependent hypertrophy (31, 32) ] and heart failure, evidence is lacking that NFATc1 plays a leading role in this disease process. In contrast to the c3 isoform, NFATc1 plays a dominant role in cardiac development. Cardiac NFATc1 controls valve formation and morphogenesis of the heart, and a disruption of this isoform results in lethal defects (3) . Thus the basal activity of NFATc1 in cardiac myocytes is likely to be required to maintain the differentiated phenotype of adult myocytes. Along this line, if the maintenance of a differentiated phenotype is controlled by NFATc1 activity, a basal nuclear localization seems prerequisite for a continuous transcriptional activity. It may be further speculated that circulating neurohumoral agonists exert a modulatory control function of NFATc1 transcriptional activity via the IP 3 /Ca 2ϩ signaling cascade. In contrast, robust and efficient nuclear extrusion mechanisms are required for the regulation of transcription factors (such as NFATc3 in this study; cf. Fig. 4 ) that remain quiescent in normal cardiac tissue and only become active in a disease state such as pathological cardiac hypertrophy. As we have shown previously (28), NFATc3 reveals an enhanced nuclear localization in myocytes from failing hearts, supporting the notion that NFATc3 (but not c1) is implicated in hypertrophic remodeling.
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